Narrow-moat CSL reiterated fiscal 2025 guidance for constant-currency group net profit after tax before amortization, or NPATA, of USD 3.2 billion to­ USD 3.3 billion, implying 1 ...

Prolacta Bioscience, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill and premature infants, announced today that the journal Foods has published ...

CSL’s balance sheet is in sound condition. Financial risk is low given low revenue cyclicality and product demand is being largely driven by chronic indications. We forecast CSL’s net debt to EBITDA ...

Plasma Fractionation Market Share 2025 Plasma fractionation is a process of separating various components of plasma, which in turn is a com ...

Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business.

Attention to detail and consistency are the keys to success with calves, according to consultant vet Tommy Heffernan. It ...

Global Bovine Colostrum market is expected to grow at a CAGR of 6.53%, reaching a market size of US$360.980 million in 2030 from US$263.128 million in 2025.

Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

Dairy-beef cross calves are vulnerable to bovine respiratory disease (BRD). Understanding triggers and management strategies can help farms meet this challenge.

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with biotechnology startup FcR Therapeutics to develop recombinant nanobodies ...

The most common symptom is tingling or weakness in arms and legs. It affects muscle control and sensory signals and can begin ...

Medically reviewed by Jurairat J. Molina, MD It can be challenging to tell the difference between a milk (dairy) allergy and a reaction to the lactose in milk (which is lactose intolerance). They can ...